// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Feasibility and Acceptability of Symptom Monitoring with Feedback Trial (SWIFT) for Adults on Hemodialysis: A Pilot ANZDATA Registry-Based Cluster Randomized Trial

Morton RachaelL - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Optimising Recruitment in Prepare for Kidney Care: A Clinical Trial Comparing Preparation for Dialysis vs. Responsive Management

Realpe AlbaX - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence of Intradialytic Hypotension Throughout a Hemodialysis Session: Does the Time of Onset Matter?

Keane DavidFrancis - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Intradialytic hypotension

N/A

Gram-Negative Bacteraemias in Haemodialysis Patients: Pathogen and Source Identification

Naito Anna - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in Sensitivity Patterns of Gram-Negative Isolates in Bacteraemic Haemodialysis Patients

Malik Fatima - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence and Outcomes of Gram-Negative Bacteraemias in Haemodialysis Patients: 12-Year Single-Centre Experience

Malik Fatima - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Disease Course of Hyperkalemia in Patients on Hemodialysis

Spinowitz BruceS - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hyperkalemia

Sodium zirconium cyclosilicate

Valvular Heart Disease in Prevalent Haemodialysis Patients

Elewa Mohamed - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac valvular dysplasia X-linked

N/A

Human Factors Testing of the Quanta SC+ Haemodialysis System: Demonstrating Ease of Use with Minimal Upfront Training in Health Care Practitioners and Patients

Komenda Paul - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute Dialysis in a High-Dependency Unit: A New Service with a Long-Term Legacy

Samad Nasreen - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Norepinephrine topical

Can COVID-19 Personal Hygiene and Social Distancing Reduce Bacteremia and Peritonitis Rates in Dialysis Patients

Samad Nasreen - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Peritonitis

N/A

Patient Outcomes of a Two-Exchange Assisted Continuous Ambulatory Peritoneal Dialysis (CAPD) Programme for Frail Older Patients

Ryan LouiseA - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient-Reported Factors and Peritonitis Risk: Results from the Optimizing Prevention of Peritoneal Dialysis-Associated Peritonitis in the US Study (OPPUS)

McCullough Keith - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Peritonitis

N/A

A Rare Cause of Peritoneal Dialysis-Associated Peritonitis

Jheeta AnupS - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Peritonitis

Biaxin

Burden of Dialysis, Health-Related Quality of Life, and Employment Comparisons Between Peritoneal Dialysis and In-Center Hemodialysis: Findings from the DOPPS Program

Brown EdwinaA - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Renal disease

N/A

The Relationship Between Comorbidities and Hyperkalaemia in Patients with CKD

Tafesse Eskinder - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-dialysis-dependent chronic kidney disease

N/A

Relationships Between CKD Duration, Serum Potassium Level, and Adverse Outcomes

Tafesse Eskinder - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Patient and Clinician Preferences for Hyperkalemia Treatment: A Qualitative Study

Israni RubeenK - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hyperkalemia

N/A

Patient Palatability and Preference Study of Three Potassium Binders in Patients with CKD and Hyperkalemia: Rationale and Design of the APPETIZE Study

James Glen - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hyperkalemia

Sodium zirconium cyclosilicate

Characteristics of CKD Patients with Hyperkalemia: A Report from the DISCOVER CKD Retrospective Cohort

James Glen - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hyperkalemia

N/A

Copyright © 2026. QuantiNova All rights reserved